Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11771682 AR+ breast cancer treatment methods

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
November 26, 2019
Date of Patent
October 3, 2023
Patent Application Number
16696110
Patent Citations
‌
US Patent 7363075 Transdermal delivery system for dried particulate or lyophilized medications
‌
US Patent 8629167 Selective androgen receptor modulators
‌
US Patent 8642632 Selective androgen receptor modulators
‌
US Patent 8987319 Selective androgen receptor modulators
‌
US Patent 9133182 Selective androgen receptor modulators
‌
US Patent 9169254 Spiroimidazolone derivative
‌
US Patent 9744149 Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
‌
US Patent 9969683 Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
‌
US Patent 10258596 Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
‌
US Patent 7097834 Osteoprotegerin binding proteins
•••
Patent Inventor Names
Jamal Saeh
Gary Hattersley
Teeru Bihani
Ziyang Yu
Chris Miller
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11771682
Patent Primary Examiner
‌
Layla Soroush

Find more entities like US Patent 11771682 AR+ breast cancer treatment methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo